Brought to you by WBIW News and Network Indiana
Last updated on Friday, January 21, 2011
(INDIANAPOLIS, IN) - A U.S. Food and Drug Administration Committee votes against recommending approval of a drug developed by Indianapolis-based Eli Lilly and company.
The committee says Amyvid was effective in detecting a plaque in the brain linked to Alzheimer's Disease, but it asked for more data on how scans would be interpreted by medical professionals.
© Ad-Venture Media, Inc. All Rights Reserved.
Click here to go back to previous page